Grab latest CBIC CIC Dumps as PDF Updated on 2026
Newly Released CIC Dumps for Infection Control Certified
NEW QUESTION # 114
A surgical team is performing a liver transplant. Which of the following represents the HIGHEST risk for transmission of a healthcare-associated infection?
- A. Airflow disruption due to personnel movement.
- B. Delayed administration of preoperative antibiotics.
- C. Failure to change surgical gloves after contamination.
- D. Using alcohol-based hand rub instead of surgical scrub.
Answer: C
Explanation:
* Glove Contamination and SSI Risk:
* Failure to change contaminated gloves increases the risk of surgical site infections (SSIs).
* Double-gloving with an outer glove change reduces contamination.
* Why Other Options Are Incorrect:
* B. Alcohol-based hand rubs: Are FDA-approved alternatives to traditional scrubs and effective.
* C. Delayed antibiotics: Increases infection risk, but immediate correction reduces harm.
* D. Airflow disruption: Can increase SSI risk, but glove contamination poses a more direct threat.
CBIC Infection Control References:
* APIC-JCR Workbook, "Surgical Infection Prevention," Chapter 6.
NEW QUESTION # 115
Which of the following is NOT valuable when using a graph to display data?
- A. X and Y axes labels and annotation where indicated
- B. Facility and time frame for data
- C. Title with topic of data
- D. Published trends for data comparison
Answer: D
Explanation:
The Certification Study Guide (6th edition) explains that graphs are most effective when they clearly communicate who, what, when, and how regarding the data being presented. Essential elements include a descriptive title, identification of the facility and time frame, and properly labeled X and Y axes with annotations as needed. These components ensure that the viewer can accurately interpret the data without additional explanation.
Published trends for data comparison, while potentially useful in separate analyses or reports, are not required elements of an individual graph and do not inherently improve the clarity of data display. Including external published trends can actually confuse interpretation if definitions, populations, or surveillance methodologies differ from the local data being presented. The study guide cautions against mixing datasets with different assumptions or collection methods in a single visual display unless clearly contextualized.
Titles clarify the subject of the graph, facility and time frame provide essential context, and axis labels ensure the viewer understands what is being measured. These are foundational principles of data visualization emphasized in infection prevention reporting and communication.
CIC exam questions frequently test the ability to distinguish between essential graph components and supplementary analytical tools. Recognizing that published comparison trends are not required-and may be misleading-reinforces good data communication practices and supports accurate interpretation by leadership and frontline staff.
Reference: Certification Study Guide (CBIC/CIC Exam Study Guide), 6th edition, Chapter 7: Management and Communication; Chapter 4: Surveillance and Epidemiologic Investigation.
NEW QUESTION # 116
Hand-hygiene audits in a long-term care facility have demonstrated consistently low levels of staff compliance. An infection preventionist is planning an education program to try to improve hand-hygiene rates. Regarding assessment of the effectiveness of the education program, which of the following is true?
- A. A change between pre- and post-test scores correlates well with the expected change in hand-hygiene compliance.
- B. An evaluation of the program is not required if the program is mandatory.
- C. Repeated observations of staff will be required in order to demonstrate that the program has been effective.
- D. A summative evaluation will accurately reflect the extent to which participants will change their hand- hygiene practices.
Answer: C
Explanation:
The correct answer is B, "Repeated observations of staff will be required in order to demonstrate that the program has been effective," as this statement is true regarding the assessment of the effectiveness of the education program. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, evaluating the impact of an education program on hand-hygiene compliance in a long-term care facility requires ongoing monitoring to assess sustained behavior change. Repeated observations provide direct evidence of staff adherence to hand-hygiene protocols over time, allowing the infection preventionist (IP) to measure the program's effectiveness beyond initial training (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs). This method aligns with the World Health Organization (WHO) and CDC recommendations for hand-hygiene improvement, which emphasize continuous auditing to ensure lasting improvements in compliance rates.
Option A (a summative evaluation will accurately reflect the extent to which participants will change their hand-hygiene practices) is incorrect because a summative evaluation, typically conducted at the end of a program, assesses overall outcomes but does not predict future behavior changes or account for long-term compliance, which is critical in this context. Option C (a change between pre- and post-test scores correlates well with the expected change in hand-hygiene compliance) is misleading; while pre- and post-tests can measure knowledge gain, they do not reliably correlate with actual practice changes, as knowledge does not always translate to behavior without observation. Option D (an evaluation of the program is not required if the program is mandatory) is false, as mandatory programs still require evaluation to verify effectiveness, especially when addressing low compliance, per CBIC and quality improvement standards.
The focus on repeated observations aligns with CBIC's emphasis on data-driven assessment to improve infection prevention practices, ensuring that the education program leads to sustained hand-hygiene improvements and reduces healthcare-associated infections (CBIC Practice Analysis, 2022, Domain II:
Surveillance and Epidemiologic Investigation, Competency 2.4 - Evaluate the effectiveness of infection prevention and control interventions).
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 - Evaluate the effectiveness of infection prevention and control interventions; Domain IV:
Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs. WHO Guidelines on Hand Hygiene in Health Care, 2009. CDC Hand Hygiene in Healthcare Settings, 2019.
NEW QUESTION # 117
Which of the following statements describes the MOST important consideration of an infection preventionist when assessing the effectiveness of an infection control action plan?
- A. Monitor and validate the related outcome and process measures.
- B. Develop a timeline and assign responsibilities for the stated action.
- C. Update the plan before the risk assessment is completed.
- D. Re-evaluate the action plan every three years.
Answer: A
Explanation:
Assessing the effectiveness of an infection control action plan is a critical responsibility of an infection preventionist (IP) to ensure that interventions reduce healthcare-associated infections (HAIs) and improve patient safety. The Certification Board of Infection Control and Epidemiology (CBIC) highlights this process within the "Surveillance and Epidemiologic Investigation" and "Performance Improvement" domains, emphasizing the need for ongoing evaluation and data-driven decision-making. The Centers for Disease Control and Prevention (CDC) and other guidelines stress that the ultimate goal of an action plan is to achieve measurable outcomes, such as reduced infection rates, which requires systematic monitoring and validation.
Option D, "Monitor and validate the related outcome and process measures," is the most important consideration. Outcome measures (e.g., infection rates, morbidity, or mortality) indicate whether the action plan has successfully reduced the targeted infection risk, while process measures (e.g., compliance with hand hygiene or proper catheter insertion techniques) assess whether the implemented actions are being performed correctly. Monitoring involves continuous data collection and analysis, while validation ensures the data's accuracy and relevance to the plan's objectives. The CBIC Practice Analysis (2022) underscores that effective infection control relies on evaluating both outcomes (e.g., decreased central line-associated bloodstream infections) and processes (e.g., adherence to aseptic protocols), making this a dynamic and essential step. The CDC's "Compendium of Strategies to Prevent HAIs" (2016) further supports this by recommending regular surveillance and feedback as key to assessing intervention success.
Option A, "Re-evaluate the action plan every three years," suggests a periodic review, which is a good practice for long-term planning but is insufficient as the most important consideration. Infection control requires more frequent assessment (e.g., quarterly or annually) to respond to emerging risks or outbreaks, making this less critical than ongoing monitoring. Option B, "Update the plan before the risk assessment is completed," is illogical and counterproductive. Updating a plan without a completed risk assessment lacks evidence-based grounding, undermining the plan's effectiveness and contradicting the CBIC's emphasis on data-driven interventions. Option C, "Develop a timeline and assign responsibilities for the stated action," is an important initial step in implementing an action plan, ensuring structure and accountability. However, it is a preparatory activity rather than the most critical factor in assessing effectiveness, which hinges on post- implementation evaluation.
The CBIC Practice Analysis (2022) and CDC guidelines prioritize outcome and process monitoring as the cornerstone of infection control effectiveness, enabling IPs to adjust strategies based on real-time evidence.
Thus, Option D represents the most important consideration for assessing an infection control action plan's success.
References:
* CBIC Practice Analysis, 2022.
* CDC Compendium of Strategies to Prevent Healthcare-Associated Infections, 2016.
NEW QUESTION # 118
An infection preventionist is evaluating a new catheter that may decrease the rate of catheter-associated urinary tract infections. Which of the following provides the BEST information to support the selection of this catheter?
- A. Product materials and vendor information
- B. Value analysis and information provided by the manufacturer
- C. Staff member preference and product availability
- D. Cost benefit analysis and safety considerations
Answer: B
Explanation:
The correct answer is D, "Cost benefit analysis and safety considerations," as this provides the best information to support the selection of a new catheter aimed at decreasing the rate of catheter-associated urinary tract infections (CAUTIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, selecting medical devices like catheters for infection prevention involves a comprehensive evaluation that balances efficacy, safety, and economic impact. A cost-benefit analysis assesses the financial implications (e.g., reduced infection rates leading to lower treatment costs) against the cost of the new catheter, while safety considerations ensure the device minimizes patient risk, such as reducing biofilm formation or irritation that contributes to CAUTIs (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This dual focus provides evidence-based data to justify the catheter's adoption, aligning with the goal of improving patient outcomes and reducing healthcare-associated infections (HAIs).
Option A (staff member preference and product availability) is subjective and logistical rather than evidence- based, making it insufficient for a decision that impacts infection rates. Option B (product materials and vendor information) offers technical details but lacks the broader context of efficacy and cost-effectiveness needed for a comprehensive evaluation. Option C (value analysis and information provided by the manufacturer) includes a structured assessment of value, but it may be biased toward the manufacturer's claims and lacks the independent safety and cost-benefit perspective critical for infection prevention decisions.
The emphasis on cost-benefit analysis and safety considerations reflects CBIC's priority on using data-driven and patient-centered approaches to select interventions that enhance infection control (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies). This approach ensures the catheter's selection is supported by robust evidence, optimizing both clinical and economic outcomes in the prevention of CAUTIs.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies; Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment.
NEW QUESTION # 119
During an outbreak of ventilator-associated pneumonia (VAP), the infection preventionist should FIRST:
- A. Perform bacterial cultures from ventilator circuits.
- B. Review adherence to ventilator bundle elements.
- C. Isolate all ventilated patients in negative pressure rooms.
- D. Implement preemptive antibiotic therapy in all ventilated patients.
Answer: B
Explanation:
* Reviewing compliance with VAP prevention bundles (e.g., head-of-bed elevation, oral care, sedation breaks) is the first step in outbreak control.
* Preemptive antibiotics (B) are not recommended due to antibiotic resistance risks.
* Negative pressure rooms (C) are not required for VAP.
* Ventilator circuit cultures (D) do not guide patient management.
CBIC Infection Control References:
* APIC Text, "VAP Prevention Measures," Chapter 11.
NEW QUESTION # 120
A healthcare professional in a clinical microbiology laboratory is concerned about routine exposure to Neisseria meningitidis in culture. The healthcare professional last received the Meningococcal vaccine 8 years ago. What recommendation should be given to the healthcare professional regarding their meningococcal vaccination?
- A. They are due for a booster as it has been over 7 years.
- B. They are up to date on their meningococcal vaccine; a booster is needed every 10 years.
- C. They are due for a booster as it has been over 5 years.
- D. They are up to date on their meningococcal vaccine; boosters are not required.
Answer: A
Explanation:
The correct answer is B, "They are due for a booster as it has been over 7 years," as this is the appropriate recommendation for the healthcare professional regarding their meningococcal vaccination. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), healthcare professionals with routine exposure to Neisseria meningitidis, such as those in clinical microbiology laboratories, are at increased risk of meningococcal disease due to potential aerosol or droplet exposure during culture handling. The quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for such individuals, with a primary series (one dose for those previously vaccinated or two doses 2 months apart for unvaccinated individuals) and a booster dose every 5 years if the risk persists (CDC Meningococcal Vaccination Guidelines, 2021). However, for laboratory workers with ongoing exposure, the ACIP specifies a booster interval of every 5 years from the last dose, but this is often interpreted in practice as aligning with the 5-7 year range depending on risk assessment and institutional policy. Since the healthcare professional received the vaccine 8 years ago and works in a high- risk setting, a booster is due, with the 7-year threshold being a practical midpoint for this scenario (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents).
Option A (they are due for a booster as it has been over 5 years) is close but slightly premature based on the 8- year interval, though it reflects the general 5-year booster guideline for high-risk groups; the 7-year option better matches the specific timeframe. Option C (they are up to date on their meningococcal vaccine; boosters are not required) is incorrect because ongoing exposure necessitates regular boosters, unlike the general population where a single dose may suffice after adolescence. Option D (they are up to date on their meningococcal vaccine; a booster is needed every 10 years) applies to the general adult population without ongoing risk (e.g., post-adolescence vaccination), not to laboratory workers with continuous exposure, where the interval is shorter.
The recommendation for a booster aligns with CBIC's emphasis on protecting healthcare personnel from occupational exposure to communicable diseases, ensuring compliance with evidence-based immunization practices (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This supports the prevention of meningococcal disease outbreaks in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.1 - Collaborate with organizational leaders, 3.2 - Implement measures to prevent transmission of infectious agents. CDC Meningococcal Vaccination Guidelines, 2021. ACIP Recommendations for Meningococcal Vaccines, 2020 (updated 2023).
NEW QUESTION # 121
An infection preventionist (IP) is notified that a patient who underwent an endoscopic brain biopsy the night before has been diagnosed with prion disease. Because the diagnosis was thought to be unlikely but possible at the time of the biopsy, the endoscope was sequestered. The endoscope manufacturer's instructions for reprocessing indicate that the endoscope can be reprocessed using high-level disinfection or low-temperature sterilization. The IP should recommend that the endoscope be:
- A. Disinfected with a 1:10 dilution of household bleach or 1N NaOH.
- B. Sterilized using ethylene oxide or hydrogen peroxide gas plasma.
- C. Autoclaved at 134°C (273°F) for 18 minutes.
- D. Bagged as biohazardous waste and discarded.
Answer: D
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies prion diseases (such as Creutzfeldt-Jakob disease) as unique and extremely challenging from an infection prevention standpoint due to the extraordinary resistance of prions to conventional disinfection and sterilization methods. Prions are not destroyed by standard high-level disinfection, low-temperature sterilization, ethylene oxide, or hydrogen peroxide gas plasma, even when manufacturer instructions for use suggest these methods for routine pathogens.
Invasive neurologic procedures involving high-risk tissues (brain, spinal cord, posterior eye) pose the greatest transmission risk. When a reusable device such as an endoscope is used on high-risk tissue in a patient with known or suspected prion disease, and the device cannot tolerate validated prion-inactivation protocols, the Study Guide recommends removal from service and disposal.
While harsh chemical treatments such as 1N sodium hydroxide or high-concentration bleach combined with extended steam sterilization may be effective for heat-resistant surgical instruments, flexible endoscopes and similar devices cannot safely undergo these processes without damage. Therefore, reprocessing is not acceptable in this scenario.
Autoclaving alone and low-temperature sterilization methods are ineffective against prions. As a result, the safest and recommended action is to bag the device as biohazardous waste and discard it, preventing any risk of iatrogenic transmission.
For the CIC exam, this question tests recognition that manufacturer IFUs do not supersede prion-specific infection prevention guidance, and patient safety requires device destruction when prion exposure cannot be reliably mitigated.
NEW QUESTION # 122
A patient with a non-crusted rash has boon diagnosed with Sarcoptes scabiei. The patient is treated with 5% permethrin and precautions are started. The precautions can be stopped
- A. when the bed linen is changed
- B. when the treatment cream is applied
- C. 24 hours after effective treatment
- D. 24 hours after the second treatment
Answer: C
Explanation:
For Sarcoptes scabiei (scabies), Contact Precautions should remain in place until 24 hours after effective treatment has been completed. The first-line treatment is 5% permethrin cream, which is applied to the entire body and left on for 8-14 hours before being washed off.
Why the Other Options Are Incorrect?
* A. When the treatment cream is applied - The mite is still present and infectious until treatment has fully taken effect.
* B. When the bed linen is changed - While changing linens is necessary, it does not indicate that the infestation has cleared.
* D. 24 hours after the second treatment - Most cases require only one treatment with permethrin, though severe cases may need a second dose after a week.
CBIC Infection Control Reference
According to APIC guidelines, Contact Precautions can be discontinued 24 hours after effective treatment has been administered.
NEW QUESTION # 123
Which of the following management activities should be performed FIRST?
- A. Evaluate project results
- B. Assign responsibility for projects
- C. Establish goals
- D. Plan and organize activities
Answer: C
Explanation:
To determine which management activity should be performed first, we need to consider the logical sequence of steps in effective project or program management, particularly in the context of infection control as guided by CBIC principles. Management activities typically follow a structured process, and the order of these steps is critical to ensuring successful outcomes.
* A. Evaluate project results: Evaluating project results involves assessing the outcomes and effectiveness of a project after its implementation. This step relies on having completed the project or at least reached a stage where outcomes can be measured. Performing this activity first would be premature, as there would be no results to evaluate without prior planning, goal-setting, and execution. Therefore, this cannot be the first step.
* B. Establish goals: Establishing goals is the foundational step in any management process. Goals provide direction, define the purpose, and set the criteria for success. In the context of infection control, as emphasized by CBIC, setting clear objectives (e.g., reducing healthcare-associated infections by a specific percentage) is essential before any other activities can be planned or executed. This step aligns with the initial phase of strategic planning, making it the logical first activity. Without established goals, subsequent steps lack focus and purpose.
* C. Plan and organize activities: Planning and organizing activities involve developing a roadmap to achieve the goals, including timelines, resources, and tasks. This step depends on having clear goals to guide the planning process. In infection control, this might include designing interventions to meet infection reduction targets. While critical, it cannot be the first step because planning requires a predefined objective to be effective.
* D. Assign responsibility for projects: Assigning responsibility involves delegating tasks and roles to individuals or teams. This step follows the establishment of goals and planning, as responsibilities need to be aligned with the specific objectives and organized activities. In an infection control program, this might mean assigning staff to monitor compliance with hand hygiene protocols. Doing this first would be inefficient without a clear understanding of the goals and plan.
The correct sequence in management, especially in a structured field like infection control, begins with establishing goals to provide a clear target. This is followed by planning and organizing activities, assigning responsibilities, and finally evaluating results. The CBIC framework supports this approach by emphasizing the importance of setting measurable goals as part of the infection prevention and control planning process, which is a prerequisite for all subsequent actions.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain V:
Management and Communication, which highlights the importance of setting goals as the initial step in managing infection control programs.
CBIC Examination Content Outline, Domain V: Leadership and Program Management, which underscores the need for goal-setting prior to planning and implementation of infection control initiatives.
NEW QUESTION # 124
The infection preventionist (IP) collaborates with the Intravenous Therapy team to select the best antiseptic for use during the insertion of an intravascular device for adults. For a patient with no contraindications, what antiseptic should the IP suggest?
- A. Povidone-iodine
- B. Alcohol
- C. Antibiotic ointment
- D. Chlorhexidine
Answer: D
Explanation:
The selection of an appropriate antiseptic for the insertion of an intravascular device (e.g., peripheral or central venous catheters) is a critical infection prevention measure to reduce the risk of catheter-related bloodstream infections (CRBSIs). The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes evidence-based practices in the "Prevention and Control of Infectious Diseases" domain, which includes adhering to guidelines for aseptic technique during invasive procedures. The Centers for Disease Control and Prevention (CDC) provides specific recommendations for skin antisepsis, as outlined in the
"Guidelines for the Prevention of Intravascular Catheter-Related Infections" (2017).
Option A, chlorhexidine, is the preferred antiseptic for skin preparation prior to intravascular device insertion in adults with no contraindications. Chlorhexidine, particularly in a 2% chlorhexidine gluconate (CHG) with
70% isopropyl alcohol solution, is recommended by the CDC due to its broad-spectrum antimicrobial activity, residual effect (which continues to kill bacteria after application), and superior efficacy compared to other agents in reducing CRBSI rates. Studies cited in the CDC guidelines demonstrate that chlorhexidine-based preparations significantly lower infection rates compared to povidone-iodine or alcohol alone, making it the gold standard for this procedure when tolerated by the patient.
Option B, povidone-iodine, is an alternative antiseptic that can be used for skin preparation. It is effective against a wide range of microorganisms and is often used when chlorhexidine is contraindicated (e.g., in patients with chlorhexidine allergy). However, its efficacy is less persistent than chlorhexidine, and it requires longer drying time, which can be a limitation in busy clinical settings. The CDC considers povidone-iodine a second-line option unless chlorhexidine is unavailable or unsuitable. Option C, alcohol (e.g., 70% isopropyl or ethyl alcohol), has rapid bactericidal activity but lacks a residual effect, making it less effective for prolonged protection during catheter dwell time. It is often used as a component of chlorhexidine-alcohol combinations but is not recommended as a standalone antiseptic for intravascular device insertion. Option D, antibiotic ointment, is not appropriate for skin preparation during insertion. Antibiotic ointments (e.g., bacitracin or mupirocin) are sometimes applied to catheter sites post-insertion to prevent infection, but their use is discouraged by the CDC due to the risk of promoting antibiotic resistance and fungal infections, and they are not classified as antiseptics for initial skin antisepsis.
The CBIC Practice Analysis (2022) supports the adoption of CDC-recommended practices, and the 2017 CDC guidelines explicitly state that chlorhexidine-based preparations with alcohol should be used for skin antisepsis unless contraindicated. For a patient with no contraindications, the infection preventionist should suggest chlorhexidine to optimize patient safety and align with best practices.
References:
* CBIC Practice Analysis, 2022.
* CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2017.
NEW QUESTION # 125
What inflammatory reaction may occur in the eye after cataract surgery due to a breach in disinfection and sterilization of intraocular surgical instruments?
- A. Bacterial conjunctivitis
- B. Toxic Posterior Segment Syndrome
- C. Endophthalmitis
- D. Toxic Anterior Segment Syndrome
Answer: D
Explanation:
The correct answer is C, "Toxic Anterior Segment Syndrome," as this is the inflammatory reaction that may occur in the eye after cataract surgery due to a breach in disinfection and sterilization of intraocular surgical instruments. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, Toxic Anterior Segment Syndrome (TASS) is a sterile, acute inflammatory reaction that can result from contaminants introduced during intraocular surgery, such as endotoxins, residues from improper cleaning, or chemical agents left on surgical instruments due to inadequate disinfection or sterilization processes (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). TASS typically presents within 12-48 hours post-surgery with symptoms like pain, redness, and anterior chamber inflammation, and it is distinct from infectious causes because it is not microbial in origin. A breach in reprocessing protocols, such as failure to remove detergents or improper sterilization, is a known risk factor, making it highly relevant to infection prevention efforts in surgical settings.
Option A (endophthalmitis) is an infectious inflammation of the internal eye structures, often caused by bacterial or fungal contamination, which can also result from poor sterilization but is distinguished from TASS by its infectious nature and longer onset (days to weeks). Option B (bacterial conjunctivitis) affects the conjunctiva and is typically a surface infection unrelated to intraocular surgery or sterilization breaches of surgical instruments. Option D (toxic posterior segment syndrome) is not a recognized clinical entity in the context of cataract surgery; inflammation in the posterior segment is more commonly associated with infectious endophthalmitis or other conditions, not specifically linked to reprocessing failures.
The focus on TASS aligns with CBIC's emphasis on ensuring safe reprocessing to prevent adverse outcomes in surgical patients, highlighting the need for rigorous infection control measures (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This is supported by CDC and American Academy of Ophthalmology guidelines, which identify TASS as a preventable complication linked to reprocessing errors (CDC Guidelines for Disinfection and Sterilization, 2019; AAO TASS Task Force Report, 2017).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 - Ensure safe reprocessing of medical equipment, 3.5 - Evaluate the environment for infection risks. CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities, 2019. AAO TASS Task Force Report,
2017.
NEW QUESTION # 126
Given the formula for calculating incidence rates, the Y represents which of the following?
- A. Population served
- B. Number of events
- C. Number of infected patients
- D. Population at risk
Answer: D
Explanation:
Incidence rate is a fundamental epidemiological measure used to quantify the frequency of new cases of a disease within a specified population over a defined time period. The Certification Board of Infection Control and Epidemiology (CBIC) supports the use of such metrics in the "Surveillance and Epidemiologic Investigation" domain, aligning with the Centers for Disease Control and Prevention (CDC) "Principles of Epidemiology in Public Health Practice" (3rd Edition, 2012). The formula provided, XY×K=Rate\frac{X}
{Y} \times K = RateYX×K=Rate, represents the standard incidence rate calculation, where KKK is a constant (e.g., 1,000 or 100,000) to express the rate per unit population, and the question asks what YYY represents among the given options.
In the incidence rate formula, XXX typically represents the number of new cases (or events) of the disease occurring during a specific period, and YYY represents the population at risk during that same period. The ratio XY\frac{X}{Y}YX yields the rate per unit of population, which is then multiplied by KKK to standardize the rate (e.g., cases per 1,000 persons). The CDC defines the denominator (YYY) as the population at risk, which includes individuals susceptible to the disease over the observation period. Option B ("Number of infected patients") might suggest XXX if it specified new cases, but as the denominator YYY, it is incorrect because incidence focuses on new cases relative to the at-risk population, not the total number of infected individuals (which could include prevalent cases). Option C ("Population at risk") correctly aligns with YYY, representing the base population over which the rate is calculated.
Option A, "Population served," is a broader term that might include the total population under care (e.g., in a healthcare facility), but it is not specific to those at risk for new infections, making it less precise. Option D,
"Number of events," could align with XXX (new cases or events), but as the denominator YYY, it does not fit the formula's structure. The CBIC Practice Analysis (2022) and CDC guidelines reinforce that the denominator in incidence rates is the population at risk, ensuring accurate measurement of new disease occurrence.
References:
CBIC Practice Analysis, 2022.
CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.
NEW QUESTION # 127
An infection preventionist has been asked to consult on disinfectant products for use in a long term care home. What should their primary concern be?
- A. An appropriate disinfectant should be available whenever items are used on patients known to be colonized with multi drug resistant organisms.
- B. Disinfectant products should be compatible with the patient care devices used by the facility.
- C. Disinfectant products should have a mild odor to reduce allergy concerns.
- D. Patient care items are cleaned whenever visibly soiled.
Answer: B
Explanation:
The most critical factor in choosing disinfectants in long-term care iscompatibility with medical devicesto prevent damage and ensure safety. Improper selection can compromise disinfection efficacy and equipment longevity.
* TheAPIC/JCR Workbookhighlights:
"Organizations should evaluate compatibility of disinfectant products with the materials used in patient care equipment. Incompatibility can lead to equipment degradation or malfunction".
* This ensures compliance with manufacturer instructions and preserves warranty and functionality.
References:
APIC/JCR Workbook, 4th Edition, Chapter 8 - Disinfection and Sterilization
NEW QUESTION # 128
A 2-yoar-old girl is admitted with a fractured tibia. At birth, she was diagnosed with congenital cytomegalovirus (CMV). Which of the following barrier precautions is appropriate for healthcare personnel caring for her?
- A. Wear masks and gloves
- B. Use gowns, masks, gloves, and a private room
- C. Wear gloves when handling body fluids
- D. No barrier precautions are needed
Answer: C
Explanation:
Standard Precautions are sufficient for congenital cytomegalovirus (CMV), which means that gloves should be used when handling body fluids. CMV is primarily transmitted via direct contact with saliva, urine, or blood.
Why the Other Options Are Incorrect?
* A. Wear masks and gloves - Masks are not necessary unless performing high-risk aerosol- generating procedures.
* C. No barrier precautions are needed - Gloves are required when handling bodily fluids to prevent transmission.
* D. Use gowns, masks, gloves, and a private room - CMV does not require Contact or Airborne Precautions.
CBIC Infection Control Reference
APIC guidelines state that CMV transmission is prevented using Standard Precautions, primarily with glove use for body fluid contact.
NEW QUESTION # 129
There are four cases of ventilator-associated pneumonia in a surgical intensive care unit with a total of 200 ventilator days and a census of 12 patients. Which of the following BEST expresses how this should be reported?
- A. 20 ventilator-associated pneumonia cases/1000 ventilator days
- B. Postoperative pneumonia rate of 6% in SICU patients
- C. More information is needed regarding ventilator days per patient
- D. Ventilator-associated pneumonia rate of 2%
Answer: A
Explanation:
The standard way to report ventilator-associated pneumonia (VAP) rates is:
Why the Other Options Are Incorrect?
* A. Ventilator-associated pneumonia rate of 2% - This does not use the correct denominator (ventilator days).
* C. Postoperative pneumonia rate of 6% in SICU patients - Not relevant, as the data focuses on VAP, not postoperative pneumonia.
* D. More information is needed regarding ventilator days per patient - The total ventilator days are already provided, so no additional data is required.
CBIC Infection Control Reference
APIC and NHSN recommend reporting VAP rates as cases per 1,000 ventilator days.
NEW QUESTION # 130
Endemic infection rate refers to
- A. Disease that overwhelms the usual healthcare system.
- B. An outbreak of disease much greater than expected in a specific population or group.
- C. The occurrence of more cases of a disease than expected in a given area or among a specific group.
- D. The usual presence of a disease in a specific population or geographical area.
Answer: D
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) defines endemic infection rate as the constant or usual presence of a disease within a specific population, geographic area, or healthcare setting. An endemic level represents the baseline or expected frequency of disease occurrence over time, allowing infection preventionists to distinguish normal disease patterns from unusual increases that may signal outbreaks or epidemics.
Option B accurately reflects this definition by describing the expected and stable presence of a disease within a defined population or location. Endemic infections may persist at low or predictable levels and do not necessarily indicate a failure of infection prevention practices. Examples include seasonal influenza in the community or baseline rates of certain healthcare-associated infections within a facility.
Option A refers to a pandemic or healthcare system overload, not endemic disease. Options C and D describe outbreaks or epidemics, which involve a sudden increase in cases above the expected endemic level. These terms imply deviation from baseline and require investigation and intervention.
Understanding endemic rates is critical for infection prevention and surveillance because they provide the comparison point for identifying trends, clusters, and outbreaks. Surveillance data are interpreted against endemic baselines to determine whether changes reflect random variation or meaningful increases requiring action.
For the CIC exam, recognizing epidemiologic terminology is essential. Endemic infection rate specifically refers to the usual or expected presence of disease, making option B the correct answer.
NEW QUESTION # 131
The primary source of organisms that cause surgical silo infections is the
- A. healthcare personnel's hands.
- B. operating room environment.
- C. patient's endogenous flora
- D. operating room personnel.
Answer: C
Explanation:
The primary source of organisms causing surgical site infections (SSIs) is the patient's own endogenous flora.
Bacteria from the skin, mucous membranes, or gastrointestinal tract contaminate the surgical site, leading to infection. Common pathogens include Staphylococcus aureus, coagulase-negative staphylococci, and Enterobacteriaceae.
Why the Other Options Are Incorrect?
* A. Operating room environment - While environmental contamination can contribute, it is not the primary source.
* B. Operating room personnel - Infection control measures (hand hygiene, gloves, masks) reduce transmission from personnel.
* D. Healthcare personnel's hands - Although hand contamination is a risk, it is secondary to the patient' s endogenous flora.
CBIC Infection Control Reference
According to APIC guidelines, the patient's own flora is the primary source of SSIs.
NEW QUESTION # 132
A patient with a non-crusted rash has boon diagnosed with Sarcoptes scabiei. The patient is treated with 5% permethrin and precautions are started. The precautions can be stopped
- A. when the bed linen is changed
- B. when the treatment cream is applied
- C. 24 hours after effective treatment
- D. 24 hours after the second treatment
Answer: C
Explanation:
ForSarcoptes scabiei(scabies),Contact Precautionsshould remainin place until 24 hours after effective treatment has been completed. The first-line treatment is5% permethrin cream, which is applied to the entire body and left on for8-14 hoursbefore being washed off.
Why the Other Options Are Incorrect?
* A. When the treatment cream is applied- Themite is still presentand infectiousuntil treatment has fully taken effect.
* B. When the bed linen is changed-While changing linens is necessary, it doesnot indicate that the infestation has cleared.
* D. 24 hours after the second treatment- Mostcases require only one treatmentwith permethrin, though severe cases may need a second dose after a week.
CBIC Infection Control Reference
According toAPIC guidelines,Contact Precautions can be discontinued 24 hours after effective treatment has been administered.
NEW QUESTION # 133
......
Latest CIC Exam Dumps CBIC Exam from Training: https://gocertify.topexamcollection.com/CIC-vce-collection.html
